Back to Search Start Over

Standardisation of optical coherence tomography angiography nomenclature in uveitis: first survey results.

Authors :
Pichi F
Salas EC
D de Smet M
Gupta V
Zierhut M
Munk MR
Source :
The British journal of ophthalmology [Br J Ophthalmol] 2021 Jul; Vol. 105 (7), pp. 941-947. Date of Electronic Publication: 2020 Jul 29.
Publication Year :
2021

Abstract

Aim: To standardise the nomenclature for reporting optical coherence angiography (OCT-A) findings in the field of uveitis.<br />Methods: Members of the International Uveitis Study Group, of the American Uveitis Society and of the Sociedad Panamericana de Infermedades Oculares that choose to participate responded to an online questionnaire about their preferred terminology when reporting on OCT-A findings in uveitis. The response of individuals with several publications on OCT-A (experts) was compared with uveitis specialists (users) who have less than five publications on the field of uveitis and OCT-A.<br />Results: A total of 108 uveitis specialists who participated in the survey were included in the analysis. Of those, 23 were considered OCT-A 'experts'. There was an agreement in both groups for the definition of wide-field (WF)-OCT-A, and definition of neovascularisation in uveitis. Moreover, there was a difference in the responses in other areas, such as quantification of ischaemia, definition of 'large' areas of ischaemia or terms to describe decreased OCT-A signal from different causes. There was an unanimous need of 'users' and 'experts' to distinguish size of decreased OCT-A signal in uveitis, to implement a quantitative measurement of decreased flow specifically for WF-OCT-A and to use different terms for different causes of decreased OCT-A signal.<br />Conclusions: While there was considerable agreement in the terminology used by all uveitis experts, significant differences in terminology were noted between 'users' and 'experts'. These differences indicate the need for standardisation of nomenclature among all uveitis specialists both for the purpose of reporting and in clinical use.<br />Competing Interests: Competing interests: None declared.<br /> (© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.)

Details

Language :
English
ISSN :
1468-2079
Volume :
105
Issue :
7
Database :
MEDLINE
Journal :
The British journal of ophthalmology
Publication Type :
Academic Journal
Accession number :
32727731
Full Text :
https://doi.org/10.1136/bjophthalmol-2020-316881